Nirvana Life Sciences (XCNQ:NIRV) Total Stockholders Equity : C$-0.81 Mil (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Total Stockholders Equity?

Nirvana Life Sciences's Total Stockholders Equity for the quarter that ended in Jan. 2024 was C$-0.81 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nirvana Life Sciences's Book Value per Share for the quarter that ended in Jan. 2024 was C$-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nirvana Life Sciences's Debt-to-Equity for the quarter that ended in Jan. 2024 was -0.03.

Nirvana Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Nirvana Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Total Stockholders Equity Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Total Stockholders Equity

Get a 7-Day Free Trial

-0.74

-0.53

-0.02

-0.16

-0.94

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															-0.55	-0.94	-0.75	-0.85	-0.81

Nirvana Life Sciences (XCNQ:NIRV) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nirvana Life Sciences's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.812	-	0)	/	48.233
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nirvana Life Sciences's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.024	+	0)	/	-0.812
	=	-0.03

Nirvana Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines